跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Flusaph-Forte - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Flusaph-Forte
Approved
STANDARD
Flusaph-Forte
Sapphire Lifesciences Pvt. Ltd..
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
c7261aab23a69c63
Company
Sapphire Lifesciences Pvt. Ltd..
Type
Standard
Approval Details
Approval Id
c7261aab23a69c63
Drug Approval Philippines Name
Flusaph-Forte
Product Name
Flusaph-Forte
Registration Number
DRP-13410
Brand Name
Flusaph-Forte
Generic Name
Paracetamol + Phenylpropanolamine (as hydrochloride) + Chlorpheniramine maleate
Dosage Form
Tablet
Dosage Strength
500 mg / 25 mg / 2 mg
Manufacturer
Sapphire Lifesciences Pvt. Ltd..
Importer
Nelpa Lifesciences, Inc.
Distributor
Nelpa Lifesciences, Inc.
Issuance Date
28 April 2023
Expiry Date
27 February 2028
Classification
Over-the-Counter (OTC)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
c7261aab23a69c63
Type
Standard
Back to Philippines FDA Approvals